NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
June 9, 2026 — Southwest Oral Surgical Arts opens a new South St. George office, offering oral surgery, periodontal treatment, and dental implants. Find an oral surgeon, periodontist, and specialist care closer to home.
June 9, 2026 — Health Talk America signs with CMP for commercial rights, sponsorships, and talent bookings. Dr. Adam Brockman also signs individually for books and revenue streams.
June 9, 2026 — Hospitals are leading efforts to make health care more affordable, according to the AHA. BioMedWire highlights key players like Astiva Health in tackling the cost crisis.
June 9, 2026 — Aptevo Therapeutics and Niowave collaborate to develop radiopharmaceutical therapies targeting metastatic cancers. Learn how their combined expertise in multispecific platforms and isotope supply advances targeted oncology treatments.
June 9, 2026 — Learn how Austin surgeon Dr. Robert Whitfield's 2024 MDPI research links bacterial biofilms on breast implants to chronic inflammation and Breast Implant Illness (BII) symptoms, offering new insights for diagnosis and treatment.
June 9, 2026 — LataMed AI Corp. evaluates deploying AI health platforms in fitness and wellness markets. Learn about their strategic growth initiative and potential impact on digital health.
June 9, 2026 — PhillComm Global adds Bond and Klarify to its client roster, expanding into AI-driven personal security and healthcare admin automation. Learn how these innovations address societal shifts.
June 9, 2026 — Dental Health and Wellness in Colorado Springs introduces biological, minimally invasive, and cosmetic dentistry under one roof. Whole-body approach connects oral health to overall wellness. Learn more.
June 9, 2026 — Charlotte Dental Associates provides affordable family dental care in Charlotte, NC, accepting NC Medicaid and NC Health Choice. Services include fillings, crowns, and cleanings from Dr. Han O and Dr. Matthew Farzin.
June 9, 2026 — Ventiv Scientific's V-PULSE Mechanical Thrombectomy System completes first-in-human cases, offering real-time aspiration control for clot removal in peripheral vasculature.
June 9, 2026 — Clear Lake Dental Care in Webster, TX offers comprehensive dental solutions including emergency, cosmetic, implant, and sedation dentistry with advanced technology and personalized care.
June 9, 2026 — Commonwealth Family Dentistry launches redesigned website for better patient access in Chester, VA. Explore cosmetic dentistry, dental implants, and sleep apnea treatment.
June 9, 2026 — Immediate kangaroo mother care (iKMC) reduces mortality and improves outcomes for preterm infants. New review in World Journal of Pediatrics supports early skin-to-skin contact as a lifesaving intervention.
June 9, 2026 — Amerigo Scientific launches research and GMP-grade small molecules for stem cell research, enabling cell reprogramming and therapy manufacturing to advance regenerative medicine.
June 8, 2026 — Regentis Biomaterials (NYSE American: RGNT) announces surgeon training for GelrinC, a CE Mark-approved knee cartilage treatment, starting Q3 2026 in Europe.
June 8, 2026 — CNS Pharmaceuticals (CNSP) completes $22.5M oversubscribed financing, CFO discusses strategic reset and acquisition-focused transformation. InvestorWire covers the virtual segment highlighting institutional investor interest and growth strategy.
June 8, 2026 — Tonix Pharmaceuticals expands TONMYA access to 52 million U.S. commercial lives via new coverage agreement. Learn about the fibromyalgia treatment and its impact.
June 8, 2026 — Regentis Biomaterials announces European surgeon training for GelrinC, a CE Mark-approved cell-free knee cartilage implant, starting Q3 2026 at Humanitas Research Hospital in Milan.
June 8, 2026 — A clinical trial shows radioactive collagen tiles reduce brain cancer recurrence and extend survival. The ROADS trial by MD Anderson offers new hope, with CNS Pharmaceuticals also advancing treatments.
June 8, 2026 — Quantum BioPharma advances LUCID-MS for multiple sclerosis, completing Phase 1 trials and submitting an IND to FDA. Learn about this novel therapy targeting myelin repair.